[1]张俊民,许爱平,赵利平,等.川崎病患儿血清酸性鞘磷脂酶、钙调神经磷酸酶水平和炎症因子表达的相关性以及与免疫球蛋白治疗效果的关系研究[J].现代检验医学杂志,2022,37(05):180-185.[doi:10.3969/j.issn.1671-7414.2022.05.036]
　ZHANG Jun-min,XU Ai-ping,ZHAO Li-ping,et al.Correlation between Serum Acid Sphingomyelinase, Calcineurin Levels and Expression of Inflammatory Factors in Children with Kawasaki Disease and the Relationship with the Therapeutic Effect of Immunoglobulin[J].Journal of Modern Laboratory Medicine,2022,37(05):180-185.[doi:10.3969/j.issn.1671-7414.2022.05.036]
点击复制

川崎病患儿血清酸性鞘磷脂酶、钙调神经磷酸酶水平和炎症因子表达的相关性以及与免疫球蛋白治疗效果的关系研究()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年05期
页码:
180-185
栏目:
检验与临床
出版日期:
2022-09-15

文章信息/Info

Title:
Correlation between Serum Acid Sphingomyelinase, Calcineurin Levels and Expression of Inflammatory Factors in Children with Kawasaki Disease and the Relationship with the Therapeutic Effect of Immunoglobulin
文章编号:
1671-7414（2022）05-180-06
作者:
张俊民; 许爱平; 赵利平; 代宝春; 张 娟
邯郸市中心医院儿科，河北邯郸 056000
Author(s):
ZHANG Jun-min;  XU Ai-ping;  ZHAO Li-ping;  DAI Bao-chun;  ZHANG Juan
Department of Pediatrics, Handan Central Hospital, Hebei Handan 056000，China
关键词:
川崎病; 酸性鞘磷脂酶; 钙调神经磷酸酶; 炎症反应; 免疫球蛋白
分类号:
R725.5；R392.11
DOI:
10.3969/j.issn.1671-7414.2022.05.036
文献标志码:
A
摘要:
目的　探讨川崎病（kawasaki disease，KD）患儿血清酸性鞘磷脂酶（acid sphingomyelinase，ASM）、钙调神经磷酸酶（calcineurin，CaN）水平和炎症因子表达的相关性以及与免疫球蛋白治疗效果的关系研究。方法　选择2017年2 月～ 2020 年3 月邯郸市中心医院收治的196 例KD 患儿（KD 组）和198 例健康体检儿童（对照组）为研究对象。检测所有儿童血清ASM，CaN 及炎症因子[ 白细胞介素（interleukin ，IL）-2，C 反应蛋白（C-reactive protein，CRP），白细胞介素（interleukin ，IL）-6，肿瘤坏死因子（tumor necrosis factor，TNF）-α] 水平。分析血清ASM，CaN 水平与IL-2，CRP，IL-6，TNF-α 的相关性。根据静脉注射免疫球蛋白（intravenous immunoglobulin，IVIG）治疗反应性将KD 患儿分为IVIG 反应组（n=165）和IVIG 无反应组（n=31），分析IVIG 治疗效果的影响因素。结果　KD组患儿血清ASM（3.31±0.75nmol/L），CaN（2.52±0.62ng/ml），IL-2（3.65±0.95pg/ml），CRP（31.15±5.34mg/L），IL-6（85.91±19.75pg/ml），TNF-α（5.19±0.98μg/L）水平均高于对照组（1.05±0.31nmol/L，0.86±0.25ng/ml，0.95±0.23pg/ml，1.32±0.27mg/L，23.15±6.59pg/ml，2.01±0.34μg/L）, 差异有统计学意义（t=33.715 ～ 41.914，均P ＜ 0.05）。Pearson 相关性分析结果显示：血清ASM，CaN 水平与IL-2，CRP，IL-6，TNF-α 水平均呈正相关（rASM=0.396 ～ 0.521，rCaN=0.342 ～ 0.512，均P ＜ 0.05）。单因素分析结果显示：IVIG 反应组血清ASM，CaN，CRP 和IL-6 水平以及发热时间、中性粒细胞比例和白细胞计数均低于IVIG 无反应组，差异有统计学意义（t=5.969 ～ 18.252，均P ＜ 0.05）。多因素Logistic 回归分析结果显示：ASM（OR=1.390，95%CI=1.158 ～ 1.669），CaN（OR=1.749，95%CI=1.346 ～ 2.272）和CRP（OR=1.865，95%CI=1.358 ～ 2.561）均是KD 患儿IVIG 治疗效果的影响因素（均P ＜ 0.05）。结论　KD 患儿血清ASM 和CaN 水平均异常升高，且血清ASM 和CaN 水平升高与机体发生炎症反应、IVIG 治疗无反应有关，检测血清ASM 和CaN 水平有助于评估KD 病情和IVIG 疗效。
Abstract:
Objective　To investigate the correlation between serum acid sphingomyelinase (ASM), calcineurin(CAN) levels and expression of inflammatory factors in children with Kawasaki disease(KD) and the relationship with the therapeutic effect of immunoglobulin. Methods　196 children with KD (KD group) who were treated in Handan Central Hospital from February 2017 to March 2020 and 198 healthy children (control group) were selected as the study subjects. The levels of serum ASM, CaN and inflammatory factors[interleukin (IL)-2, C-reactive protein (CRP), interleukin (IL)-6 and tumor necrosis factor (TNF)-α] were detected in all children. The correlation of serum ASM and CaN levels with IL-2, CRP, IL-6 and TNF-α were analyzed. According to intravenous immunoglobulin therapy (IVIG) treatment response, children with KD were divided into IVIG response group (n=165 ) and IVIG non-response group (n=31) treatment response. The influencing factors of IVIG treatment effect were analyzed. Results　The levels of serum ASM（3.21±0.75nmol/L）, CaN（2.52±0.62ng/ml）, IL-2（3.65±0.95pg/ml）, CRP（31.15±5.34mg/L）, IL-6（85.91±19.75pg/ml）and TNF-α（5.19±0.98μg/L）in KD group were higher than those i n cont r o l g r o up（1. 0 5 ± 0 .31nmol /L， 0 .86± 0 .25ng/ml ，0. 9 5 ± 0 .23pg/ml ， 1 .32± 0 .27mg /L，23.15±6.59pg/ml，2.01±0.34μg/L）, the differences were statistically significant（t=33.715 ～ 41.914，all P ＜ 0.05）. Pearson correlation analysis showed that serum ASM and CaN levels were positively correlated with IL-2, CRP, IL-6 and TNF-α levels（rASM=0.396 ～ 0.521，rCaN=0.342 ～ 0.512，all P ＜ 0.05）. Univariate analysis showed that the levels of serum ASM, CAN, CRP, IL-6 levels, heating time, neutrophil proportion and white blood cell count in IVIG response group were lower than those in IVIG non-response group，the differences were statistically significant（t=5.969 ～ 18.252，all P ＜ 0.05）. Multivariate Logistic regression analysis showed that ASM（OR=1.390，95%CI=1.158 ～ 1.669），CaN（OR=1.749， 95%CI=1.346 ～ 2.272）and CRP（OR=1.865，95%CI=1.358 ～ 2.561）were the influencing factors of IVIG treatment effectin children with KD (all P<0.05). Conclusion　The serum ASM and CaN levels in children with KD were abnormally increased, and the increase of serum ASM and CaN levels were related to the inflammatory reaction in the body and the nonresponse to IVIG treatment. The detection of serum ASM and CaN levels is helpful to evaluate the disease of KD and the efficacy of IVIG.

参考文献/References:

[1] SUN Yameng, LIU Jingjing, GENG Zhimin, et al.The elevated serum levels of calcineurin and nuclear factor of activated T-cells 1 in children with Kawasaki disease[J]. Pediatric Rheumatology Online Journal,2020, 18(1): 23.
[2] 林瑶, 李晓惠, 石琳, 等.2017 年版《川崎病的诊断、治疗及远期管理- 美国心脏协会对医疗专业人员的科学声明》解读[J]. 中国实用儿科杂志, 2017,32(9):641-648.
LIN Yao, LI Xiaohui, SHI Lin, et al. Interpretation of the 2017 edition of diagnosis, treatment, and longterm management of Kawasaki disease :A scientific statement for health professionals from the American Heart Association[J]. Chinese Journal of Practical Pediatrics, 2017,32(9):641-648.
[3] 蔡琍璇, 麦隽, 翁陈华, 等. 静脉注射免疫球蛋白无反应型川崎病的临床特征[J]. 广东医学, 2008,29(3):491-493.
CAI Lixuan, MAI Jun, WENG Chenhua, et al.Clinical features of Kawasaki disease unresponsive to intravenous immunoglobulin[J]. Guangdong Medical Journal,2008, 29(3):491-493.
[4] 王娟, 马飞艳, 樊萍. 血清ASM 与GPx 水平检测与类风湿性关节炎膝关节病变的相关性研究[J]. 现代检验医学杂志, 2020, 35(4):61-64.
WANG Juan, MA Feiyan, FAN Ping. Study on the relationship between serum levels of ASM and GPx,and Rheumatoid Arthritis [J]. Journal of Modern Laboratory Medicine,2020,35(4):61-64.
[5] MURATA K, MOTOMURA Y, TANAKA T, et al.Calcineurin inhibitors exacerbate coronary arteritis via the MyD88 signalling pathway in a murine model of Kawasaki disease[J]. Clinical and Experimental Immunology, 2017, 190(1): 54-67.
[6] MCCRINDLE B W, ROWLEY A H, NEWBURGER J W, et al. Diagnosis, treatment, and Long-Term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017, 135(17):e927-e999.
[7] OLIVIERI L, ARLING B, FRIBERG M, et al.Coronary artery Z score regression equations and calculators derived from a large heterogeneous population of children undergoing echocardiography[J].Journal of the American Society of Echocardiography,2009, 22(2): 159-164.
[8] AGARWAL S, AGRAWAL D K. Kawasaki disease:etiopathogenesis and novel treatment strategies[J].Expert Review of Clinical Immunology, 2017, 13(3):247-258.
[9] RIFE E, GEDALIA A. Kawasaki disease: an update[J].Current Rheumatology Reports, 2020, 22(10): 75.
[10] 胡秀芬, 温宇. 丙种球蛋白无反应型川崎病的发病机制及治疗进展[J]. 中华实用儿科临床杂志, 2017,32(21):1612-1616.
HU Xiufen, WEN Yu. Pathogenesis and treatment of intravenous immunoglobulin-resistant Kawasaki disease[J]. Chinese Journal of Applied Clinical Pediatrics,2017,32(21):1612-1616.
[11] 张芝艳, 朱洁, 钮建宏, 等. 川崎病患者对静注丙种球蛋白无反应的影响因素及冠状动脉损伤程度[J].山东医药, 2014, 54(41):65-66.
ZHANG Zhiyan, ZHU Jie, NIU Jianhong, et al. Factors influencing nonresponse to intravenous injection of gamma globulin and severity of coronary artery injury in Kawasaki disease patients[J]. Shandong Medical Journal,2014, 54(41):65-66.
[12] 王颖, 袁越, 高路, 等. 静脉注射免疫球蛋白无反应川崎病的危险因素分析[J]. 北京医学, 2020, 42(11):1062-1065.
WANG Ying, YUAN Yue, GAO Lu, et al. Risk factors of non-response to intravenous immunoglobin in Kawasaki disease [J]. Beijing Medical Journal, 2020,42(11):1062-1065.
[13] SIMONIS A, SCHUBERT-UNKMEIR A. The role of acid sphingomyelinase and modulation of sphingolipid metabolism in bacterial infection[J]. Biological Chemistry, 2018, 399(10): 1135-1146.
[14] 潘玮, 石瑞正, 张国刚. 酸性鞘磷脂酶和心血管疾病的研究进展[J]. 中国心血管杂志, 2011, 16(3):233-234.
PAN Wei, SHI Ruizheng, ZHANG Guogang. Research progress of acid sphingomyelinase and cardiovascular diseases[J]. Chinese Journal of Cardiovascular Medicine,2011,16(3):233-234.
[15] 苏玉婷, 孟星星, 程耀萍, 等. 血管紧张素II 经酸性鞘磷脂酶/ 神经酰胺通路致动脉内皮功能障碍的作用[J]. 心脏杂志, 2017, 29(1): 34-39.
SU Yuting, MENG Xinxin, CHENG Yaoping, et al.Acid sphingomyelinase/ceramide mediates arterial angiotensin Ⅱ -induced endothelial dysfunction [J].Chinese Heart Journal, 2017, 29(1):34-39.
[16] B?LL S, ZIEMANN S, OHL K, e t a l . Acid sphingomyelinase regulates T(H) 2 cytokine release and bronchial asthma[J]. Allergy, 2020, 75(3): 603-615.
[17] LI Cao, WANG Anni, WU Yuqing, et al. Acid Sphingomyelinase-Ceramide system in bacterial infections[J]. Cellular Physiology and Biochemistry,2019, 52(2): 280-301.
[18] TARASOVA E O, GAYDUKOV A E, BALEZINA O P. Calcineurin and its role in synaptic transmission[J].Biochemistry Biokhimiia, 2018, 83(6): 674-689.
[19] ZHANG Yu, LIU Rongbei, CAO Qian, et al. USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance[J]. The Journal of Clinical Investigation, 2019, 129(7): 2856-2871.
[20] BIJNENS J, MISSIAEN L, BULTYNCK G, et al.A critical appraisal of the role of intracellular Ca2+-signaling pathways in Kawasaki disease[J]. Cell Calcium, 2018, 71: 95-103.
[21] LI Min, FANG Xiangzhi, LIU Xiaotian, et al.Inhibition of calcineurin/NFATc4 signaling attenuates ventilator-induced lung injury[J]. Molecular Medicine Reports, 2020, 21(2): 607-614.
[22] CHENG Jinbo, TANG Wei, SU Zhenyi, et al.Calcineurin subunit B promotes TNF-alpha-induced apoptosis by binding to mitochondria and causing mitochondrial Ca2+ overload[J]. Cancer Letters, 2012,321(2): 169-178.

相似文献/References:

[1]盛伟武,高春彪,管华玲.miRNA-145和miRNA-143在川崎病患儿血浆中的表达及意义[J].现代检验医学杂志,2016,31(05):34.[doi:10.3969/j.issn.1671-7414.2016.05.009]
　SHENG Wei-wu,GAO Chun-biao,GUAN Hua-ling.Expression and Its Significance of MicroRNA-145 and MicroRNA-143 in Plasma in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2016,31(05):34.[doi:10.3969/j.issn.1671-7414.2016.05.009]
[2]靳剑芸,李启亮,宋文琪.血浆血栓弹力图与抗凝血酶Ⅲ检测对儿童川崎病诊断的应用价值[J].现代检验医学杂志,2017,32(05):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
　JIN Jian-yun,LI Qi-liang,SONG Wen-qi.Correlation Discussion of Blood Plasma Thromboelastography Values and Antithrombin III Level in Children's Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2017,32(05):130.[doi:10.3969/j.issn.1671-7414.2017.05.017]
[3]刘丽莎,李喆倩,谈 诚,等.川崎病并发冠脉损伤患儿血清活化HUVECs NF-κB促使MMP-9 mRNA水平上调的实验研究[J].现代检验医学杂志,2018,33(01):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
　LIU Li-sha,LI Zhe-qian,TAN Cheng,et al.Experimental Study on the Up-Regulation of NF- kappa B and MMP-9 mRNA Level in HUVECs Stimulated by Serum from Children with Coronary Artery Lesions of Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2018,33(05):131.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[4]李俏,张李钰,赵传梅,等.西安地区儿童免疫球蛋白无反应型川崎病危险因素分析及预测评分体系的建立[J].现代检验医学杂志,2019,34(01):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
　LI Qiao,ZHANG Li-yu,ZHAO Chuan-mei,et al.Analysis of Risk Factors of Intravenous Immunoglobulin in Children with Non-Responsive Kawasaki Disease in Xi’an Area and Establishment of Its Predictive Scoring System[J].Journal of Modern Laboratory Medicine,2019,34(05):5.[doi:10.3969/j.issn.1671-7414.2019.01.002]
[5]王 娟,马飞艳,樊 萍.血清ASM 与GPx 水平检测与类风湿性关节炎膝关节病变的相关性研究[J].现代检验医学杂志,2020,35(04):61.[doi:10.3969/j.issn.1671-7414.2020.04.015]
　WANG Juan,MA Fei-yan,FAN Ping.Study on the Relationship between Serum Levels of ASM and GPx, and Rheumatoid Arthritis[J].Journal of Modern Laboratory Medicine,2020,35(05):61.[doi:10.3969/j.issn.1671-7414.2020.04.015]
[6]张书婉,黄君华,吴文婧,等.外周血 NLR 与 PLR 对儿童完全型川崎病冠状动脉损伤的预测分析[J].现代检验医学杂志,2020,35(06):38.[doi:doi:10.3969/j.issn.1671-7414.2020.06.010]
　ZHANG Shu-wan,HUANG Jun-hua,WU Wen-jing,et al.Prediction Analysis of NLR and PLR for the Development of Coronary ArteryLesions in Patients with Complete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2020,35(05):38.[doi:doi:10.3969/j.issn.1671-7414.2020.06.010]
[7]马飞艳,王　娟,樊　萍.川崎病患儿血清趋化素和缺血修饰清蛋白水平与冠状动脉损伤的相关性及在治疗中的应用价值[J].现代检验医学杂志,2021,36(03):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
　MA Fei-yan,WANG Juan,FAN Ping.Relationship between the Levels of Chemokine and Ischemia-modified Albuminin Serum and Coronary Artery Injury in Children with Kawasaki Disease and the Application Value in the Treatment[J].Journal of Modern Laboratory Medicine,2021,36(05):72.[doi:10.3969/j.issn.1671-7414.2021.03.016]
[8]黄君华,崔自明,张书婉,等.完全性川崎病患儿血清 25-羟基维生素 D水平检测对预测 IVIG抵抗的价值研究[J].现代检验医学杂志,2022,37(01):28.[doi:10.3969/j.issn.1671-7414.2022.01.006]
　HUANG Jun-hua,CUI Zi-ming,ZHANG Shu-wan,et al.Value of Serum 25-Hydroxyvitamin D Levels in the Prediction of Intravenous Immunoglobulin Resistance in Patients withComplete Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2022,37(05):28.[doi:10.3969/j.issn.1671-7414.2022.01.006]
[9]李月悦a,唐 莉a,朱明跃b.川崎病患儿血清CTRP9 和sCD146 水平表达与冠状动脉损伤的相关性研究[J].现代检验医学杂志,2024,39(03):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]
　LI Yueyuea,TANG Lia,ZHU Mingyueb.Correlation between the Expression Levels of Serum CTRP9 and sCD146 and Coronary Artery Lesions in Children with Kawasaki Disease[J].Journal of Modern Laboratory Medicine,2024,39(05):170.[doi:10.3969/j.issn.1671-7414.2024.03.029]

备注/Memo

备注/Memo:
基金项目：2017 年度河北省医学科学研究重点课题计划（编号：201701849）。
作者简介：张俊民（1977-），女，本科，主治医师，从事儿科方面的研究，E-mail：zjm3313015634@163.com。
更新日期/Last Update: 2022-09-15